These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25248790)

  • 1. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
    Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
    Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUX1-Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors.
    Krug S; Weissbach J; Blank A; Perren A; Haybaeck J; Fendrich V; Rinke A; Gress TM; Rosendahl J; Michl P
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32707646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer.
    Ripka S; Neesse A; Riedel J; Bug E; Aigner A; Poulsom R; Fulda S; Neoptolemos J; Greenhalf W; Barth P; Gress TM; Michl P
    Gut; 2010 Aug; 59(8):1101-10. PubMed ID: 20442202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.
    Ripka S; Riedel J; Neesse A; Griesmann H; Buchholz M; Ellenrieder V; Moeller F; Barth P; Gress TM; Michl P
    Neoplasia; 2010 Aug; 12(8):659-67. PubMed ID: 20689760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
    Xu Q; Wang Z; Chen X; Duan W; Lei J; Zong L; Li X; Sheng L; Ma J; Han L; Li W; Zhang L; Guo K; Ma Z; Wu Z; Wu E; Ma Q
    Oncotarget; 2015 Mar; 6(7):4717-32. PubMed ID: 25605248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling.
    Kühnemuth B; Mühlberg L; Schipper M; Griesmann H; Neesse A; Milosevic N; Wissniowski T; Buchholz M; Gress TM; Michl P
    Oncogene; 2015 Jan; 34(2):177-87. PubMed ID: 24336331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
    Chen J; Zhou Z; Yao Y; Dai J; Zhou D; Wang L; Zhang QQ
    J Cell Mol Med; 2018 Oct; 22(10):4760-4770. PubMed ID: 30010249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
    Sampedro-Núñez M; Luque RM; Ramos-Levi AM; Gahete MD; Serrano-Somavilla A; Villa-Osaba A; Adrados M; Ibáñez-Costa A; Martín-Pérez E; Culler MD; Marazuela M; Castaño JP
    Oncotarget; 2016 Feb; 7(6):6593-608. PubMed ID: 26673010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production.
    Fan Y; Gan Y; Shen Y; Cai X; Song Y; Zhao F; Yao M; Gu J; Tu H
    Oncotarget; 2015 Jun; 6(18):16120-34. PubMed ID: 25948792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.
    de Sá SV; Corrêa-Giannella ML; Machado MC; de Souza JJ; Pereira MA; Patzina RA; Siqueira SA; Machado MC; Giannella-Neto D
    Endocr Relat Cancer; 2006 Mar; 13(1):69-78. PubMed ID: 16601280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.
    Hamze Z; Vercherat C; Bernigaud-Lacheretz A; Bazzi W; Bonnavion R; Lu J; Calender A; Pouponnot C; Bertolino P; Roche C; Stein R; Scoazec JY; Zhang CX; Cordier-Bussat M
    Endocr Relat Cancer; 2013 Dec; 20(6):833-48. PubMed ID: 24157940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
    Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
    Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of astrocyte-elevated gene-1 is associated with cervical carcinoma progression and angiogenesis.
    Long M; Dong K; Gao P; Wang X; Liu L; Yang S; Lin F; Wei J; Zhang H
    Oncol Rep; 2013 Sep; 30(3):1414-22. PubMed ID: 23835593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.
    Dong YD; Cui L; Peng CH; Cheng DF; Han BS; Huang F
    Oncol Rep; 2013 Jan; 29(1):87-94. PubMed ID: 23042506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
    Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.
    Zumsteg A; Caviezel C; Pisarsky L; Strittmatter K; García-Echeverría C; Hofmann F; Christofori G
    Mol Cancer Res; 2012 Jun; 10(6):800-9. PubMed ID: 22562956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer.
    Togashi Y; Kogita A; Sakamoto H; Hayashi H; Terashima M; de Velasco MA; Sakai K; Fujita Y; Tomida S; Kitano M; Okuno K; Kudo M; Nishio K
    Cancer Lett; 2015 Jan; 356(2 Pt B):819-27. PubMed ID: 25449777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.